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The purpose of this paper is to provide a critical appraisal of the article “Rate and maintenance of 
improvement of myofascial pain with dry needling alone vs. dry needling with intramuscular 
electrical stimulation: a randomized controlled trial.” This appraisal began as an attempt to find 
relevant research comparing the practice of dry needling (DN) to dry needling with 
intramuscular electrical stimulation (DN/IMES) with regards to treating myofascial pain 
syndrome (MPS). The article was found through the Gale Onefile database, and it directly 
compares the two methods in questions. The authors make a thorough introduction of DN, 
DN/IMES and MPS, siting previous studies done on the topics, and identifying outcome 
measures for their own study. This single-blinded study compared two research groups, one 
receiving DN treatment and the other DN/IMES, without having a non-treatment control group 
to compare to. Both groups saw statistically significant improvement in NPRS and NDI scores 
over the 12-week period. However, the authors fail to recognize the potential benefits of the 
DN/IMES seeing significant improvements in NDI scores over the first 3 weeks, while the DN 
group did not. The authors do not use the MCID scores for NDI or NPRS to determine clinical 
significance. If they did, they would see that the DN/IMES group was the only one with 
clinically significant improvements throughout the study. Both DN and DN/IMES have the 
potential to relieve pain in patients with MPS. While the authors of the article fail to recognize 
the differences between the DN and DN/IMES groups, their data shows that DN/IMES at least 
has the potential to provide quicker and longer lasting pain relief. Further research is needed, 
using clinically accurate methods, to firmly establish whether one treatment method is more 










MPS caused by myofascial trigger points (MTrPs) can be a significant source of pain for athletes 
and individuals. Without ever even pulling a muscle, the pain from these trigger points can be 
severe enough to limit performance and interfere with activities of daily living. Interventions 
such as DN have sought to relieve the pain caused by MTrPs. The addition of intramuscular 
electrical stimulation to DN has been introduced to further improve the results of DN on MPS 
relief. The purpose of this critical appraisal is to evaluate the validity of this article’s claim that 
DN/IMES is no more effective at treating MPS than DN alone. 
Methods 
Research began with the intent to compare DN to DN/IMES at relieving MPS.  By searching 
various databased with the search terms “dry needling” and “electrical stimulation” the Gale 
Onefile database had the most articles on the subject. The article was subsequently chosen from 
these results. Limits placed on the search results included “full articles” in order to analyze 
methods and results of studies. Studies met the inclusion criteria if they were blinded clinical 
trials with human subjects. Total search hits found before choosing an article was 44. 
The article, mentioned above, was chosen from these results. It was published in the Journal of 
Manual & Manipulative Therapy in 2021 and was written by Kindyle Brennan, Katherine M. 
Elifritz, Megan M. Comire and Daniel C. Jupiter. The study was conducted at the University of 
Mary Hardin-Baylor. This article was chosen because it directly compared the two modalities in 
question and met the inclusion criteria. 
Results 
MPS is defined as “the presence of sensory, motor, and/or autonomic symptoms caused by the 
presence of MTrPs.” MTrPs are characterized as “hyperirritable nodules located within a taut 
 
 
band of muscle.” The article attempts to identify whether the practice of DN is improved with 
the addition of intramuscular electrical stimulation in treating MPS. The researchers gathered 53 
volunteer participants from the community, each of which had “at least one palpable myofascial 
trigger point” in their upper trapezius. After being randomly assigned to either DN or DN/IMES 
groups, participants underwent treatment by a licensed professional who’d been practicing DN 
for 9 years. Treatments occurred once a week for 6 weeks for both groups. Outcome measures 
used were the Neck Disability Index (NDI) and the Numeric Pain Rating Scale (NPRS) 
presented to the subjects at 3-week intervals starting with the first treatment. Results showed no 
statistically significant difference between the groups regarding demographics or baseline NDI 
or NPRS. The DN group showed statistically significant improvements in NDI and NPRS over 
the 6-week treatment period, but not within the first 3 weeks. The DN/IMES group showed 
significant improvements in NDI scores at both 3 and 6 weeks, and significant NPRS 
improvements after 6 weeks. Both groups maintained improved NDI and NPRS scores 6 weeks 
after treatments stopped. According to the study, there was no significant evidence to support 
that DN/IMES is any more effective at treating MPS than DN alone. 
Appraisal of the study introduction 
The introduction thoroughly summarizes MPS and the reasons why finding alternative methods 
of treating it would be beneficial. It sites current research stating the effectiveness of DN while 
also explaining where research is lacking. It further introduces the practice of DN/IMES and 
summarizes several relevant studies in support of it as well. Most of the studies referenced were 
from credible journals and were written within the last decade. The conclusion from the literature 
sited is that both methods, DN and DN/IMES provide positive results to patients with MPS. Both 
dependent and independent variables were identified. The introduction is very well written and 
 
 
clearly explains the objective of the study, hypothesizing that DN/IMES is no more effective 
than DN alone.  
Appraisal of the study methods 
This is an experimental, single blinded, prospective, cross-sectional study comparing two groups, 
one receiving DN treatment and the other receiving DN/IMES to treat MTrPs of the upper 
trapezius. 53 volunteers met the inclusion criteria. 8 individuals discontinued after trials began (5 
from scheduling issues and 3 from vasovagal responses associated with the trial). The 
researchers recognized that performing these interventions in sitting rather than in prone could 
“lead to a vasovagal response” yet continued this treatment method anyways. The article claims 
that this method was chosen for “pragmatic reasons”, but it is unclear what those reasons are. Of 
the 3 individuals who left the study due to vasovagal responses, 2 were from the DN group and 1 
was from the DN/IMES group. This could have implications on how electrical stimulation 
affects the vasovagal response to DN, but overall, it is statistically insignificant. Group 
assignments were random and blinded however, the individuals conducting the study and the 
clinicians were not. There was no, non-treatment control group in the study, making it difficult to 
know if the treatments are contributing to improvement or simply the body’s natural healing 
process. The interventions used were well detailed and could be easily replicated by another 
study group. Each group received intervention once a week. While this was probably done for 
scheduling purposes, it does not reflect a realistic patient population of individuals seeking 
outpatient physical therapy to treat MPS, who would likely receive interventions at least twice a 
week. The NDI and NPRS were used as outcome measures. Both tools are subjective to patient 
perception and reliability of the tools was not clear. Data was analyzed and compared using a t-
test which suits a comparison of two groups.  
 
 
Appraisal of the study results 
The results section of the article establishes congruency between the two groups prior to 
experimentation and goes on to state the NDI and NPRS scores collected throughout the study. 
Improvement was measured using these results. Statistically speaking, NPRS scores improved 
significantly from week 0 to week 6 for both groups (p=.02 for both). NDI scores for DN/IMES group 
improved significantly between week 0 to week 3 (p=.029) and both groups improved significantly from 
week 0 to week 6 (p<.001 for DN/IMES group and p=.01 for DN group). NPRS is a scale from 0-10 
with a Minimal Clinically Important Difference score (MCID) of 1 point for musculoskeletal pain. The 
DN/IMES achieved this over the 12-week study while the DN group did not. NDI is a scale of 0-50 with 
the MCID being 7.5. The DN/IMES group showed more improvement but neither group met the MCID. 
MCID and applying the statistical analysis to clinical outcomes was not touched on by the authors of the 
article.  
Appraisal of the study discussion 
The authors do not dive deeply into the meaning of their findings other than restating them and 
comparing them to other studies. Limitations of the study are recognized as the sample group not being 
“representative of the overall population,” the methodology “was not performed exactly to clinical 
standard,” and the subjects were treated while sitting, which could “lead to a vasovagal response” 
instead of in prone. Researchers also “discovered a ceiling effect with the NDI, because baseline NDI 
scores were 6.5/50 and 8.5/50 for the DN and DN/IMES groups, respectively. Scores of < 5.0 out of 50 
are classified as ‘no disability’, leaving little room for improvement.” Their conclusion seems to be 
biased toward their initial hypothesis without recognizing the differences between the group findings. 
While the group findings were very similar, the DN/IMES group was the only one with statistically 
significant changes within the first 3 weeks. The DN/IMES is also the only group to meet MCID criteria 
 
 
for any category. Authors of the article recognize that “more investigation into intermediate and long-
term follow-up is warranted” and that “more studies are needed to investigate whether IMES is a worthy 
adjunct to DN.” Long term follow-up with the study group seems unnecessary, as neither DN nor 
DN/IMES are shown to prevent future MTrPs and new pain after 6 weeks of discontinued use may be 
due to new MTrPs’. The authors fail to mention potential implications of their study other than “dry 
needling treatment continues to demonstrate promise for the treatment of MPS.” They fail to recognize 
the potential implications of DN/IMES showing more rapid NDI score improvement. 
Discussion 
This study has the potential to add additional tools to the repertoire of physical therapists who 
treat patients with MPS. While the authors fail to recognize the potential implications of the 
faster and more sustained recovery of DN/IMES, the data collected could indicate faster, longer 
lasting improvements for patients with MPS. This could help athletes return to competitions and 
patients return to activities of daily living quicker with more sustained relief. 
The research on DN and DN/IMES is still limited, and the claims of this article do not favor one 
method over the other. However, both DN and DN/IMES are shown to be safe and effective 
methods to treat MPS. Further research on both methods is recommended with methods more 
accurately resembling clinical practice in order to study the full potential of either method. 
While the authors seem intent on proving their hypothesis to be valid, the data obtained through 
their study, and the studies referenced in their article, would justify using either method, DN or 
DN/IMES, on a patient with MPS. Both practices are already being performed safely and 
appropriately in clinics throughout the United States for treatment of MTrPs. DN and DN/IMES 
appear to be useful methods allotted to physical therapists to relieve pain.  
 
 
The authors of this article have done thorough literary research on DN, DN/IMES, and MPS. 
Their research methods, while lacking a non-treatment control group, where thorough and 
showed relevant data pertaining to the improvement of pain caused by MPS using these 
treatments. While clear implications of the potential benefits of either DN or DN/IMES are not 
stated in the article itself, physical therapists should feel comfortable using either method to treat 
patients with MPS based on current research. 
 
